Clinical Significance of an HPV DNA Chip Test with Emphasis on HPV-16 and/or HPV-18 Detection in Korean Gynecological Patients

Min-Kyung YEO; Ahwon LEE; Soo-Young HUR; Jong-Sup PARK.
Journal of Pathology and Translational Medicine ; : 294-299, 2016.
Artículo en Inglés | WPRIM | ID: wpr-32744

Documentos relacionados

  1. Squamous cell carcinoma antigen combined with HPV-16 infection in predicting high-grade squamous intraepithelial lesions of the cervix.
  2. Incidence of cervical high-grade squamous intraepithelial lesions and squamous cell carcinoma in women with high-risk human papillomavirus and normal cervical cytology: A retrospective analysis of 1858 cases stratified by age and human papillomavirus genotype.
  3. Challenging lesions in cervical cytology: The elusive HSIL.
  4. The ATHENA HPV study underrepresents "other" high-risk HPV genotypes when compared with a diverse New York City population.
  5. Safety and efficacy of mucosal immunotherapy using human papillomavirus (HPV) type 16 E7-expressing Lactobacillus-based vaccine for the treatment of high-grade squamous intraepithelial lesion (HSIL): the study protocol of a randomized placebo-controlled clinical trial (MILACLE study).
  6. The role of cervical elastography in the differential diagnosis of preinvasive and invasive lesions of the cervix.
  7. Cervical Local Immune Response for High-Risk Human Papillomavirus Infection: Involvement With Cervical Mucus SLPI Proteins.
  8. Higher clearance rates of multiple HPV infections may explain their lower risk of HSIL: A retrospective study in Wenzhou, China.
  9. Prognostic Value of Human Papillomavirus Genotyping before and after Cervical Conization for Squamous Intraepithelial Lesion.
  10. Human Papillomavirus Genotypes Predict Progression of Anal Low-Grade Squamous Intraepithelial Lesions.